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Abstract
Background: Intestinal mucosa barrier (IMB) dysfunction results in many notorious diseases for which there are currently
few effective treatments. We studied curcumin’s protective effect on IMB and examined its mechanism by using
methotrexate (MTX) induced rat enteritis model and lipopolysaccharide (LPS) treated cell death model.
Methodology/Principal Findings: Curcumin was intragastrically administrated from the first day, models were made for 7
days. Cells were treated with curcumin for 30 min before exposure to LPS. Rat intestinal mucosa was collected for
evaluation of pathological changes. We detected the activities of D-lactate and diamine oxidase (DAO) according to
previous research and measured the levels of myeloperoxidase (MPO) and superoxide dismutase (SOD) by colorimetric
method. Intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor a (TNF-a) and interleukin 1b (IL-1b) were
determined by RT-PCR and IL-10 production was determined by ELISA. We found Curcumin decreased the levels of D-
lactate, DAO, MPO, ICAM-1, IL-1b and TNF-a, but increased the levels of IL-10 and SOD in rat models. We further confirmed
mitogen-activated protein kinase phosphatase-1 (MKP-1) was activated but phospho-p38 was inhibited by curcumin by
western blot assay. Finally, NF-kB translocation was monitored by immunofluorescent staining. We showed that curcumin
repressed I-kB and interfered with the translocation of NF-kB into nucleus.
Conclusions/Significance: The effect of curcumin is mediated by the MKP-1-dependent inactivation of p38 and inhibition of
NF-kB-mediated transcription. Curcumin, with anti-inflammatory and anti-oxidant activities may be used as an effective
reagent for protecting intestinal mucosa barrier and other related intestinal diseases.
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Introduction
Intestinal mucosa barrier (IMB), the first line of defense against
hostile environment, is composed of a single layer of columnar
epithelium and inter-epithelial tight junctions. It has the function
of selectively absorption nutrients and resists pathogens, toxins and
inflammatory factors invasion. Clinical and lab researches showed
that variety of factors could weaken or undermine the intestinal
barrier structure and function, such as trauma, sepsis[1],
operation, chemotherapy, radiotherapy, severe pancreatitis, long-
term parenteral nutrition, and so on, thus resulted in bacteria
translocation, subsequently led to endogenous infection and
endotoxiemia (ETM). The final consequence of IMBdysfunction
is systemic inflammation response syndrome (SIRS) and multiple
organs dysfunction syndrome (MODS) [2]. Intestine is considered
to be not only the target organ of MODS, but also the initiator of
MODS. Therefore, IMB function has become an important
prognostic indicator for critically ill patients [3].
Correctly assessing IMB function is very important for
evaluating the patient’s condition, estimating prognosis, and
providing comprehensive treatment. However, due to no difficulty
for directly observation of intestinal barrier function, currently
work is mostly carried out byexamining indirect molecular level.
D-lactate, a particular final metabolic product of bacteria in
gastrointestinal tract, will release into blood when intestinal
mucosa barrier is damaged. Examination of D-lactate in
peripheral blood can evaluate damage situation of intestinal
mucosa because of lack of D-lactate dehydrogenase in mammals
[4]. The other indicator is Diamine oxidase (DAO), one kind of
endocellular enzyme, only exists in villus cytoplasm of intestinal
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cells are injured, endocellular DAO released into the intestinal
intercellular space, entered into the lymph vessel and the blood,
finally resulted a stable high level of DAO in blood plasma. Hence,
the activity of DAO in blood indicates maturity and integrity of
intestinal mucosa [5]. Above all, the evaluation of IMB function is
depended on these two indicators in our research.
Based on an accurate assessment of IMB function, here, we
intend to find a proper drug capable for protecting it, and thus for
prevention and treatment of intestinal inflammation [6–8]. In
recent years, researchers focused on the traditional Chinese
medicine for its better therapeutic effects and less toxic side effects.
Curcumin,isolated from the rhizomes of the plant Curcuma longa
Linn, has anti-inflammation, anti-oxidization and free radical
removal effects [9]. Tremendous research papers have reported
intriguing pharmacologic effects associated with curcumin. It can
attenuate experimental colitis by inhibiting the activation of NF-
kB and reducing the activity of p38 MAPK[10–12]. Curcumin
can also suppress the activation of NF-kB in ethanol-induced liver
injury in rats [13]. The previous research showed that the
inhibition of inhibitory factor I-kB kinase activity is a possible
mechanism by which curcumin blocks NF-kB activation [14].
Moreover, curcumin was proved to suppress the p38, JNK and
NF-kB p65 in human intestinal epithelial HT29 cell line.
Curcumin also attenuated Stx-1 induced cell death [15]. Hence,
the evidences from the studies both in vitro and in vivo indicated that
curcumin acted as a protective reagent against inflammation or
infection.
Unfortunately, how the mechanism of curcumin mediates the
effect mentioned above is still unknown. In this study, using rat
model of enteritis and intestinal epithelial damage, we evaluated
the protective role of curcumin on IMB function. Then, we
establishedthe model of cell damage to identify the potentially
activation of epithelial intra- and extra-cellular MAKP and NF-kB
signaling pathways. These data clarified the molecular mechanism
of curcumin in protecting IMB. Our study provides a traditional
Chinese medicine, curcumin, for treating IMB dysfunction and
improving inflammatory bowel diseases (IBD) and other related
intestinal diseases.
Methods
1 Ethics Statement
All experimental procedures on rats were approved by the
Committee on the Ethics of Animal Experiments of Southern
Medical University (Permit Number: 14-2527). All surgery was
performed under sodium pentobarbital anesthesia, and all efforts
were made to minimize suffering.
2 Animals and blood samples
SD rats, weighing 200–250 g (10–12weeks), purchased from the
Laboratory Animal Center (Southern Medical University, China)
were used. Rats were raised under standard conditions (12-hour
day-night rhythm) in the Animal Care Facility Service (Southern
Medical University, China). This study was carried out in strict
accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of
Health. 15 rats were used as minimum sample size per group in all
animal experiments.
3 MTX-induced enteritis rat model
Enteritis was induced in rats through peritoneal injection of
MTX (20 mg/kg) [16]. Rats were randomly divided into 4 groups:
control group (peritoneal injection of normal saline only), MTX
group (MTX, 20 mg/kg), MTX+curcumin group (MTX, 20 mg/
kg; curcumin, 100 mg/kg) and MTX+NAC positive control group
(MTX, 20 mg/kg; NAC, 150 mg/kg). From the first day that the
rat models were made, different drugs were intragastrically
administrated with the specified dosage once a day for 7 days.
Rats in control group and MTX group were injected with saline
(Fig. 1).
4 Reagents and apparatus
Curcumin (2 g/L, 95%), D-lactate standard solution and D-
lactate dehydrogenase, O-dianisidine, cadaverine dihydrochloride,
horseradish peroxidase, LPS, bovine insulin, DAO standard
solution and SB203580 (SB, inhibitor of p38) were all purchased
from Sigma company. N-acetylcysteine (NAC) and MTX were
purchased in Zhejiang Wanma Pharmaceutical Co., Ltd. and
Shanghai Sunve Pharmaceutical Co., Ltd. respectively.
5 The disease activity index (DAI), colonic mucosal
damage index (CMDI) and histological score (HS) of the
rats were evaluated
DAI were evaluated based on the general symptoms of rats
during the disease progress including weight decent percentage,
stool viscidity and bloody stools according to the scoring system
[17]. On the 7th day animal models were made, the rats were
killed, and the intestinal segments of rats were observed with
unaided eye to determine the CMDI [18]. Severity of colitis was
graded on a scale of 0–IV and defined as the pathological index
according to the standard scoring system [19]. Finally, the
intestinal mucosa samples were fixed in 10% formaldehyde
solution at room temperature according to standard method.
Briefly, samples were embedded in paraffin, then sectioned at
5 mm, and stained with Hematoxylin-Eosin, picked up on glass
slides for light microscopy. All samples were evaluated and by an
experienced pathologist who is blinded to the experiment. Finally,
we got histological score (HS) for each samples [20].
6 Rats blood samples
7 days after MTX injection, the rats were anesthetized and a
3 mL sample of venous blood was collected. The blood samples
were injected into dry test tubes and separated by centrifugation,
the serum was stored at 220uC until use.
7 Detection of the levels of plasma D-lactate and DAO in
the small intestinal mucosa by spectrophotometry
After the plasma was deproteined with perchloric acid, the levels
of D-lactate and DAO in the serum were detected by
Figure 1. Construction of MTX induced enteritis animal model.
Schedule of rat experimental procedure is shown by a diagram. Enteritis
was induced in rats through peritoneal injection of MTX (20 mg/kg).
Control group was only treated with saline. From the first day that the
rat models were made, the drugs, curcumin or NAC, were intragastri-
cally administrated with the specified dosage once a day for 7 days,
then all rats were anesthetized and killed.
doi:10.1371/journal.pone.0012969.g001
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lectures [12,17].
8 Detection of MPO and SOD Activity in intestinal
mucosa
7 days after MTX injection, the rats were anesthetized, the
abdomens were opened along the median line, and the small
intestine was rapidly excised, the rinsed gently with ice-cold PBS,
placed on ice, and opened longitudinally. The small intestine was
incised, and the fecal contents were washed out gently with
223 ml of PBS. The ileum within 0.5 cm of the ileocecal junction
(about 1 cm) was excised with a sharp scalpel, weighted, fixed with
3 fold phosphate buffer (0.1 M, pH 7.2), homogenated, and
centrifugalized (10000 rpm/min, 30 min). The levels of MPO and
SOD in the supernatant were determined using the colorimetric
method according to the manufacturer’s protocol.
9 Cell culture and treatment
Murine IEC-6 small intestine follicular epithelial cells cell line,
purchased from Cancer Institute of Chinese Academy of Medical
Sciences, were grown in Dul-becco’s modified Eagle’s medium
(DMEM, GIBCO, USA) supplemented with 15% FBS (HyClone,
Logan, UT), 1% non-essential amino acid, 0.1% sodium pyruvate,
and 0.1% bovine insulin. IEC-6 cells were grown in petri dishes at
a density of 1610
6 cells per well, and randomly divided into 4
groups: control group and LPS group (untreated or treated with
0.1 ml LPS); LPS+curcumin group and LPS+SB positive control
group (treated with 10 mmol/L curcumin or 10 mmol/L SB for
30 min before exposure to LPS). At the indicated time points
following LPS stimulation, cells were harvested.
10 RNA isolation and RT-PCR
Total RNA was isolated using TRIzol reagent (Invitrogen
Corporation, Carlsbad, CA) according to the manufacturer’s
instructions. RT-PCR was carried out using 1 or 3 mg of total
RNA from intestinal mucosa from the rat or IEC-6 cells,
respectively. The mRNA expression levels of the following 4
genes were quantitated (TNF-a; interleukin-1b, IL-1b; IL-10;
ICAM-1). The sequences of PCR primer pairs used for each gene
are shown in Tab. 1. GADH and b-actin were used as invariant
housekeeping gene internal controls. RT-PCR was performed by
annealing at 58uC with 30 cycles.
11 ELISA
The amount of IL-10 in rat blood plasma and IEC-6 cell
supernatants were determined in duplicate using ELISA kits (R&D
System Europe Ltd., UK) as described by the manufacturer
12 Western blotting
Whole protein lysates of intestinal tissues and IEC-6 cells were
used. Atotal of 30 mg of protein were used per lane. Primary
antibodies were anti-total p38antibody, anti-phosphorylated p38
antibody, anti-phosphorylated ERK 1/2 antibody, anti-phosphor-
ylated JNK 1/2 antibody (both 1:1000, Cell Signaling Technology,
USA), anti-I-kB antibody, anti-MKP-1 antibody, anti-phosphory-
lated MKP-1 antibody (both 1:1000, Santa Cruz, USA). Secondary
antibodieswerehorseradishperoxidase-coupledanti-rabbit (1:5000,
Santa Cruz, USA). Chemoluminescence (ECL, Amersham, NO)
was used for detection, according to the manufacturer’s protocol.
13 Immunofluorescence
Nuclear extracts were prepared as described previously [21].
Use NF-kB activation-translocation detection kit to detect the
location of NF-kB, according to the manufacturer’s instructions.
14 Statistical analysis
SPSS11.5 was used as the statistical software. All analyses were
showed as mean6standard deviation (SD). Group comparisons
were performed using the one-way analysis of variance (ANOVA)
test and correlations were tested by Pearson’s rank correlation
coefficient. p values ,0.05 were considered statistically significant.
Results
1 Curcumin possesses anti-inflammatory effect in the
MTX-induced enteritis rat models
First, we examined weight, stool viscidity and bloody stools of
experimental rats to get DAI scores. Second, we observed mucosa
samples of enteritis rats to get CMDI and HS scores (The DAI,
CMDI and HS scores were shown in Tab. 2). We found that DAI,
CMDI and HS scores of experimental groups treated with
curcumin or NAC were lower than those of MTX groups
(p=0.000). But no significant difference between MTX+curcumin
group and MTX+NAC group were observed in these indexes
(p=0.65). The results above illustrated that curcumin could
obviously alleviate the inflammation reaction and symptoms of
enteritis in rats.
2 Curcumin decreases the levels of D-lactate and DAO in
the intestinal mucosa
Spectrophotometry results revealed that the levels of D-lactate
and DAO in MTX group were distinctly higher than those in
control group (p=0.000), but the levels of D-lactate and DAO in
MTX+curcumin group and MTX+NAC group were markedly
lower than those in MTX group in the same period (p=0.000)
(Fig. 2).
3 Curcumin decreases the levels of MPO and ICAM-1 in
rat enteritis intestinal mucosa and in LPS treated IEC-6
cells
We showed that in MTX group, the level of MPO in rat
enteritis intestinal mucosa was significantly higher than it in
control group p=0.000), but in MTX+curcumin group and
MTX+NAC group, it was markedly decreased (p=0.000). We
found the similar results in the MTX+NAC group. Furthermore,
ICAM-1 mRNA was also down-regulated in MTX induced
Table 1. Sequence of the amplification primers in the 59 to 39
orientation.
Primer PCR product (bp)
TNF-a S CGTCGTAGCAAACCACCAAG 426
A CACAGAGCAATGACTCCAAAG
IL-1b S AATACCACTTGTTGGCTTA 130
A TGTGATGTTCCCATTAGAC
IL-10 S GGTCTTTAGTTCCTCGTA 306
A GCTATGTTGCCTGCTCTT
ICAM-1 S AACGACGCTTCTTTTGCTC 433
A CTCTGGCGGTAATAGGTGTAA
GAPDH S ACCACAGTCCATGCCATCAC 452
A TCCACCACCCTGTTGCTGTA
doi:10.1371/journal.pone.0012969.t001
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curcumin (Fig. 3).
4 Curcumin suppresses the expression of pro-
inflammatory cytokines in rat enteritis mucosa and
supernatant of LPS treated IEC-6 cells
To detect whether curcumin has the same effect on the
expression of RT-PCR assays. We demonstrated that expression of
TNF-a and IL-1b mRNAs were alldecreased by treating with
curcumin or NAC in rat enteritis model (Fig. 4). We also
confirmed the same result in LPS treated IEC-6 cells (Fig. 4).
5 Curcumin increases the level of IL-10 in rat blood
plasma in MTX group and in the supernatant of LPS
treated IEC-6 cells
The expression level of IL-10, detected by ELISA, was significantly
lower in MTX group than it in control group (p=0.000) (Fig. 5). The
expression level of IL-10 in MTX+curcumin group and MTX+NAC
group were higher than it in MTX group (p=0.000). We found no
significant differences of IL-10 expression between the MTX+curcu-
min group and MTX+NAC group (p=0.43). We showed the same
result in LPS treated IEC-6 cells (Fig. 5)
6 Curcumin induces the level of SOD in the intestinal
mucosa
Our results indicated that the level of SOD was decreased in
MTX group compared with control group (p=0.000), but
curcumin or NAC could reverse this effect. The level of SOD
was significantly higher in MTX+curcumin or MTX+NAC group
than it in MTX group (p=0.000) but lower than it in control
group (Fig. 6).
7 Curcumin attenuates phospho-p38 but has no effect
on phospho-JNK1/2 and phospho-Erk1/2
It is known that inflammation is triggered by intracellular
signaling pathway events, which involve the activation of MAPK.
In order to further understand the underlying mechanisms of
curcumin-mediated anti-inflammation, we examined whether
curcumin could inhibit activation of MAPK signaling molecules
including p38, Erk1/2, and JNK1/2. We used western bolt to
detect the levels of total and phosphorylated p38, phosphorylated
Erk1/2, and phosphorylated JNK1/2 related in MAPK signal
pathway in the small intestinal tissue of experiment rats following
treatment with or without curcumin. Results indicated that the
total protein levels of p38 were not changed in four groups. But the
Table 2. The DAI, CMDI and HS scores in four Groups.
Group Time (day) Dose (mg/kg) DAI CMDI HS
Control 6 — 0.1260.09* 0.3060.19* 0.1660.12*
MTX 6 — 2.9961.02 2.9261.14 2.8461.20
MTX+Cur 6 100 1.5060.87*
# D 1.8160.80*
# D 1.8961.31*
# D
MTX+NAC 6 100 1.5160.60*
# 1.5960.79*
# 1.9060.89*
#
F — — 56.458 987.235 153.362
P — — 0.000 0.000 0.000
*p=0.000 vs. control group;
#p=0.000 vs. MTX group;
DP=0.65 vs. MTX+NAC group (n=15, mean 6SD).
doi:10.1371/journal.pone.0012969.t002
Figure 2. Effects of curcumin on DAO and D-lactate activities in small intestinal mucosa. (A) MTX distinctly increased the level of D-lactate,
but curcumin depressed the level of it. (B) The level of DAO were highter in MTX group compared to control group but lower in MTX+curcumin
group The same results were found in MTX+NAC group. The levels of DAO and D-lactate of the small intestinal were detected by UV-
spectrophotometry. *p=0.000 vs. control group, #p=0.000 vs. MTX group.
doi:10.1371/journal.pone.0012969.g002
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activated in rat enteritis mucous of MTX group, then we found
that treatment with curcumin or NAC resulted in a reduction in
p38 phosphorylation (p=0.000), but not of that in Erk1/2 and
JNK1/2 (Fig. 7). These observations suggested that curcumin
might inhibit the activation of the p38 kinases but not the Erk1/2
and JNK1/2.
8 Curcumin increases the expression of phospho-MKP-1
in LPS-stimulated IEC-6 cells
MKP-1, one of the dephosphorylated factors of MAPK, which
can inhibit the activity of ERK, JNK and p38 in stress
reaction[22,23], participates in regulation of multiple physiological
and pathological processes, including inflammatory reaction by
regulating the activity of ERK, JNK and p38. Recent findings
showed that MKP-1 deficiency could induce the activation of p38
and JNK phosphorylation. This prompted us to explore whether
MKP-1 was involved in the curcumin-induced attenuation of p38.
We examined total MKP-1 and its phosphorylation state in LPS-
stimulated IEC-6 cells (Fig. 8). Results indicated that LPS alone
enhanced both total and phosphorylated MKP-1 compared with
those in control group (p,0.05), and that curcumin or SB in
combination with LPS further enhanced the levels of MKP-1
phosphorylation, compared to those observed in the presence of
LPS alone (p=0.000). This demonstrated that LPS could increase
the expression of total and phospho-MKP-1, while curcumin or
SB might amplify this result.
9 Curcumin inhibits LPS-induced degradation of I-kB and
restrains translocation of NF-kB and pro-inflammatory
cytokine product
Beside MAPK signal pathway, NF-kB pathway is the most
importantdownstream signal transductionpathway mediatedby LPS
[24–27]. Some studies have shown that activation of MAPK
phosphorylation transduction signals could activate downstream
transcription of NF-kB-mediated pro-inflammatory cytokines. We
intended to investigate whether curcumin could result in inactivation
of NF-kB signal pathway. First, we evaluated the protein level of I-kB
to which inactivated NF-kB was bounded. We found that the
expression of I-kB in control group was higher than itin MTX group
(p=0.000), while it in MTX+curcumin group and MTX+NAC
group were both lower than it in control group (p,0.01) but higher
than it MTX group (p=0.000) (Fig. 9). Curcumin played the same
role as SB in LPS treated IEC-6 cell (Fig. 9).
Then, we examined whether curcumin could block NF-kB
translocation into nucleus, since nuclear translocation was often
recognized as cell reaction to LPS stimulation and seemed to
correlate with NF-kB-mediated transcriptional activation. So, we
Figure 3. Effects of curcumin on MPO and ICAM-1 activity in vivo and in vitro. (A) The level of MPO in small intestinal mucosa was
increased after treated with curcumin or NAC. The level of MPO was determined using the colorimetric method. *p=0.000 vs. control group,
#p=0.000 vs. MTX group. (B) ICAM-1 mRNA was down-regulated by curcumin or NAC in the intestinal mucosa of experiment rats. (C). ICAM-1 mRNA
was down-regulated by curcumin or SB in LPS treated IEC-6 cells. The levels of ICAM-1 mRNA were detected by RT-PCR.
doi:10.1371/journal.pone.0012969.g003
Figure 4. Effects of curcumin on the mRNA levels of TNF-a and IL-1b. (A) The expressions of TNF-a and IL-1b mRNA in MTX group were
increased, but it was inhibited after treating with curcumin or NAC. (B) The expressions of TNF-a and IL-1b in LPS treated IEC-6 cells were also
increased, but it was depressed by curcumin or SB. The levels of TNF-a and IL-1b mRNA were detected by RT-PCR.
doi:10.1371/journal.pone.0012969.g004
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IEC-6 cells in the presence or absence of curcumin in order to
indentify whether NF-kB were activated. We clearly showed that
NF-kB p65 expressed in endochylema but not in nucleus in
normal IEC-6 cells (Fig. 10). LPS stimulation led to an increase in
p65 levels in the nucleus, while treatment of 1.curcumin or SB
restrained this effect (Fig. 10). According to this, we suggested that
curcumin not only indirectly suppressed activation of NF-kB but
controlled the translocation of NF-kB into the nucleus in vitro. This
was the same as the inhibitory effect of SB.
Discussion
Intestinal epithelial barrier, including biotic barrier, mechanical
barrier and immunity barrier, is known as a very crucial barrier
against pathogen infection,especially the immunity barrier. Up to
Figure 5. Effects of curcumin on the level of IL-10. (A) The level of IL-10 was decreased in MTX group, but increased after treating with
curcumin or NAC. *p=0.000 vs. control group, #p=0.000 vs. MTX group. (B) The level of IL-10 was decreased in the supernatant of LPS treated IEC-6
cells. Both Curcumin and SB promoted the expression of IL-10. *p=0.000 vs. control group, #p=0.000 vs. LPS group. The level of IL-10 was detected
by ELISA.
doi:10.1371/journal.pone.0012969.g005
Figure 6. Effects of curcumin on small intestinal SOD activity. The level of SOD was inhibited by MTX, while elevated by treating with
curcumin or NAC. The levels of SOD in the intestinal mucosa were determined using the colorimetric method. *p=0.000 vs. control group, #p=0.000
vs. MTX group.
doi:10.1371/journal.pone.0012969.g006
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necessary to develop natural medicines effective for IMB
dysfunction and the intercurrent diseases.
In this report, we focused on curcumin with anti-inflammation
and anti-oxidization effects and commonly used in traditional
medicine in many Asian countries. First, in order to indentify the
Figure 7. Effect of curcumin on phosphorylation sate of p38. (A) The expressions of total p38, phosphorylation sates of p38, Erk1/2, and JNK1/
2 were all enhanced in MTX group. Only the phosphorylation sate of p38 was attenuated by treating with curcumin or NAC. The expressions of
phosphorylated or total proteins were detected by western blot. (B) The bar graph was a clear reflection of the level of phosphorylation sate of p38
among four groups. *p=0.000 vs. control group, #p=0.000 vs. MTX group.
doi:10.1371/journal.pone.0012969.g007
Figure 8. Effect of curcumin on both total MKP-1 and its phosphorylation state in LPS-stimulated IEC-6 cells. (A) The expressions of
total MKP-1 and phospho MKP-1 were highest in LPS+curcumin group and LPS+SB group, middle in LPS treated IEC-6 cells, and lowest in control
group. The levels of total or phosphorylated proteins were detected by western blot. (B) (C) The bar graphs were a clear reflection of the level of total
MKP-1 and phosphor-MKP-1 among four groups. #p,0.05 vs. control group; Dp=0.00 vs. LPS group.
doi:10.1371/journal.pone.0012969.g008
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group, but increased by curcumin or NAC. (B) The bar graph was a clear reflection of the level of I-kB among four groups. #p=0.000 vs. MTX group,
Dp,0.01 vs. control group (C) The expression of I-kB protein was decreased in LPS group, but increased after treating curcumin or SB. (D) The
expression of I-kB protein in LEC-6 cells was showed in bar graph. #p=0.000 vs. LPS group, Dp,0.01 vs. control group. The level of I-kB protein was
detected by western blot.
doi:10.1371/journal.pone.0012969.g009
Figure 10. Effect of curcumin on blocking NF-kB translocation into nucleus. (A) NF-kB p65 was located in the cytoplasm in control group
(white arrow). (B) NF-kB p65 translocated to nucleus after stimulated by LPS (white arrow). (C) Curcumin attenuated the translocation of NF-kB p65 to
nucleus (white arrow). (D) SB inhibited the translocation of NF-kB p65 into the nucleus (white arrow). These were observed by immunofluorescence.
Magnification6400.
doi:10.1371/journal.pone.0012969.g010
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model by MTX, and detected the two indicators, D-lactate and
DAO, to examin extent of damage and repair of rat intestinal tract
which associate with IMB function. We found that the general
condition, diarrhea and bloody stool symptoms were relieved in
MTX+curcumin group and MTX+NAC group. DAI, CMDI and
HS were also relieved after treated with curcumin or NAC
(Tab. 2). Data showed that curcumin reduced the levels of D-
lactate and DAO in MTX-induced rat enteritis model (Fig. 2).
This proved that curcumin improved the permeability of the
intestinal mucosa, reduced the extent of intestinal mucosa damage
and finally protected IMB function.
The pathophysiological process of intestinal structural damage
is as follows: intestinal mucosa cells release chemokine and
cytokines after stimulated by causative factors; inflammatory cells
infiltrate and release inflammatory mediators; finally lead to cell
death or apoptosis [28]. Leukocyte’s over-activation is a very
important knot of this process. The level of MPO, an enzyme
mainly existing in neutrophil, reflects the level of neutrophil
infiltration. We indicated that the level of MPO was clearly
decreased in curcumin or NAC treated group (Fig. 3A), which
suggested curcumin inhibited neutrophil infiltration in vivo.I n
addition, Leukocyte’s stagnation and infiltration also depend on
the expression and function of ICAM, one kind of glycoprotein,
which promotes cell-cell or cell extracellular matrix adhesion.
Moreover, ICAM-1, belonging to the immunoglobulin superfam-
ily, has received the attention in recent years in the process of
IBD[29–30]. Our data showed that the mRNA expression of
ICAM-1 was significantly suppressed by curcumin in vitro and in
vivo (Fig. 3B and C). All of this results suggested that curcumin
played anti-inflammatory role partly by inhibiting neutrophil
infiltration and its over-activation.
The imbalance of pro-inflammatory cytokines and anti-inflam-
matory cytokines is another important injury mechanism of
intestinal mucosal. IL-1b, a classic pro-inflammatory cytokine, is
an important mediator of inflammation in variety of clinically
stressful conditions. It also served as the mediator for intestinal
mucosa injury[31–33]. TNF-a participates in early steps of
inflammation, causes aggregation of inflammatory cells and plays
important roles in inducting expression of other inflammatory
cytokines[34].InthepathogenesisofIBD,TNF-aparticipatesinthe
progress of granuloma formation. To study the effect of curcumin
on pro-inflammatory cytokines, we used RT-PCR to determine the
mRNA level of IL-1 and TNF-a. Our results showed that the
mRNA expressions of IL-1 and TNF-a were significantly
suppressed by curcumin in intestinal mucosa of MTX induced rat
models and LPS-induced IEC cells (Fig. 4). On the other hand, IL-
10, identified as an anti-inflammatory cytokine, suppresses T
lymphocytes and mononuclear cell function and many pro-
inflammatory cytokines [35–37]. We detected the level of IL-10
by ELISA, and discovered that it was up-regulated by curcumin in
vivo and in vitro (Fig. 5A and B). Curcumin down-regulated pro-
inflammatory cytokine expression, while up-regulated anti-inflam-
matory cytokine production in vivo and in vitro, thereby, the anti-
inflammatory effect of curcumin was further confirmed.
Additionally, reactive oxygen species (ROS) plays a ‘‘trigger’’
role in the pathophysiological process of intestinal structural
damage [38–40]. We tested curcumin for its ability to inhibit the
combined inflammatory and oxidative damage which occured as a
response to inflammatory in the enteritis rat models. Researchers
have proved that anti-oxidant function of intestinal mucosa was
damaged in the animal model of salmonella infection, chronic
diarrhea and ulcerative colitis, and oxygen free radical scavenger
could be used to treat such diseases [41–43]. The anti-oxidant
defense system in the intestinal mucosa for eliminating ROS,
contains enzymes system and non-enzymes system. The former
includes SOD, Catalase (CAT), and Glutathione peroxidase
(GSH-Px). Here, we selected SOD, the endogenous superoxide
anion radical scavenger, as an anti-oxidant indicator, because
SOD showed the body’s ability of eliminating free radicals. Our
results demonstrated that the level of SOD was increased in the
MTX induced rat intestinal mucosal after treated with curcumin
(Fig. 6). Based on this, we suggested that curcumin has certain
effect on anti-oxidant and eliminating free radicals.
Next, we made in-depth research on possible molecular
mechanisms of curcumin. Accumulating evidence supported that
intestinal injury, including ischemic, inflammation, apoptosis and
other pathological mechanisms were related with the regulation of
MAPK [20] and NF-kB signal pathway [15,21,44–50]. The
expression of IL-10 is under the control of the Sp1 transcription
factor that is also regulated by MAPK pathway [51]. Therefore,
we disscused the role of curcumin on two pathways. MAPK which
consists of three major subgroups, ERK1/2, JNK1/2 and p38
MAPK plays a key role in transducing various extracellular signals
to nucleus and regulating cell growth and differentiation.
Moreover, MAPK takes part in the LPS-mediated signal
transduction pathway [52–54] and controls cellular responses to
cytokines and stressors. In present study, we demonstrated that
curcumin restrained the phosphorylation of p38 MAPK, but not
ERK1/2 and JNK1/2 (Fig. 7A and B). These suggested that the
anti-inflammatory effect of curcumin was partly due to the
inhibition of p38 activity.
MKP-1, another special MAPK family, is capable of dephos-
phorylating and inactivating various members of the MAPK
family [55,56]. It is reported that MKP-1 deficiency enhanced
phosphorylation of p38 and JNK [57]. Our results revealed that
both total MKP-1 and phospho-MPK-1 was obviously activated
by treatment with curcumin in LPS treated IEC-6 cells (Fig. 9).
Thus we proved that curcumin might inhibit the phosphorylation
of p38 by activating MKP-1, and eventually reduced the
inflammatory response. Curcumin had no effect on the ERK1/2
and JNK1/2 MAKP might be because these were not effective
downstream substrate of MKP-1.
Besides, NF-kB is known as a key factor in up-regulating
inflammatory cytokines. NF-kB activation enhances the transcrip-
tion of pro-inflammatory cytokines, and the cytokines are known
to in-turn activate NF-kB [58]. Thus we still detected whether
curcumin could regulat NF-kB signal pathway. NF-kB is located
in cytoplasm and bounds to I-kB as an inactive complex. The
phosphorylation and subsequent degradation of I-kB result in
separation of the complex, and then NF-kB is activated. The
activated NF-kB migrates into the nucleus, and causes the
expression of inflammatory cytokines, such as TNF-a, IL-6 and
IL-8 [59]. Meanwhile, NF-kB can be activated by inflammatory
factors such as IL-1b and TNF-a [60]. In addition NF-kB
signaling pathway is the downstream pathway of LPS-mediated
transduction pathways. Here, we displayed the level of I-kB was
degradated in MTX-induced rat intestinal mucosa and LPS-
treated IEC-6 cells, while it was increased after given curcumin
(Fig. 9). Hence, we considered that the degradation of I-kB was
abolished when treated with curcumin in vivo and in vitro. These
observations explained that curcumin could inhibit I-kB degrada-
tion, while indirectly repressed NF-kB activation. Then we further
detected the effect of curcumin on NF-kB translocation.
Immunofluorescence data showed that LPS promoted transloca-
tion of NF-kB p65 into nucleus, but curcumin inhibited this effect
(Fig. 10). The above-mentioned data showed that curcumin could
not only inhibit the activation of NF-kB but also control the
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curcumin on the production of inflammatory factors and cytokine
probably occurred via the NF-kB signaling pathway.
Overall, our results proved that curcumin has effect on anti-
inflammation, anti-oxidation and free radical removal not only in
vitro but in vivo. We futher demonstrated curcumin restrained the
activation of p38 MAPK via enhancing MKP-1 phosphorylation,
but not ERK1/2 and JNK1/2 MAPK in vitro. Besides, our results
suggested that curcumin restrained the activation and transloca-
tion of NF-kB. Taken together, we have a better understanding of
the molecular mechanism of curcumin on protecting IMB. Such
effect is mediated by a blocking of p38 MAPK via enhancing
MKP-1 phosphorylation and inhibiting NF-kB activation. We
suggested curcumin had a remarkable protective effect for IMB
and therapeutical effect on various human inflammatory diseases.
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